Wilkins Investment Counsel’s Amgen AMGN Stock Holding History

Wilkins Investment Counsel’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$264K	Hold	751	–	–	0.04%	110
2025 Q4	$246K	Hold	751	–	–	0.04%	112
2025 Q3	$212K	Hold	751	–	–	0.03%	117
2025 Q2	$210K	Hold	751	–	–	0.03%	118
2025 Q1	$234K	Buy	+751	New	+$222K	0.03%	119
2024 Q4	–	Sell	-751	Closed	-$242K	–	129
2024 Q3	$242K	Hold	751	–	–	0.03%	120
2024 Q2	$235K	Hold	751	–	–	0.04%	120
2024 Q1	$214K	Buy	+751	New	+$220K	0.03%	126
2022 Q1	–	Sell	-1,800	Closed	-$405K	–	80
2021 Q4	$405K	Hold	1,800	–	–	0.09%	70
2021 Q3	$383K	Hold	1,800	–	–	0.09%	70
2021 Q2	$439K	Hold	1,800	–	–	0.11%	65
2021 Q1	$448K	Sell	1,800 -1,700	-49%	-$406K	0.12%	64
2020 Q4	$805K	Hold	3,500	–	–	0.22%	55
2020 Q3	$890K	Hold	3,500	–	–	0.27%	53
2020 Q2	$826K	Hold	3,500	–	–	0.26%	53
2020 Q1	$710K	Sell	3,500 -500	-13%	-$109K	0.26%	55
2019 Q4	$964K	Hold	4,000	–	–	0.27%	54
2019 Q3	$774K	Hold	4,000	–	–	0.23%	57
2019 Q2	$737K	Hold	4,000	–	–	0.22%	58
2019 Q1	$760K	Hold	4,000	–	–	0.23%	54
2018 Q4	$779K	Hold	4,000	–	–	0.26%	54
2018 Q3	$829K	Hold	4,000	–	–	0.25%	54
2018 Q2	$738K	Hold	4,000	–	–	0.23%	56
2018 Q1	$682K	Hold	4,000	–	–	0.22%	60
2017 Q4	$696K	Sell	4,000 -275	-6%	-$48.7K	0.21%	60
2017 Q3	$797K	Hold	4,275	–	–	0.24%	59
2017 Q2	$736K	Buy	4,275 +50	+1%	+$8.13K	0.23%	58
2017 Q1	$693K	Buy	4,225 +50	+1%	+$8.31K	0.22%	58
2016 Q4	$610K	Buy	4,175 +100	+2%	+$15.1K	0.19%	63
2016 Q3	$680K	Hold	4,075	–	–	0.23%	56
2016 Q2	$620K	Hold	4,075	–	–	0.21%	61
2016 Q1	$611K	Buy	4,075 +75	+2%	+$11.1K	0.22%	60
2015 Q4	$649K	Hold	4,000	–	–	0.24%	55
2015 Q3	$553K	Hold	4,000	–	–	0.21%	62
2015 Q2	$614K	Hold	4,000	–	–	0.22%	58
2015 Q1	$639K	Hold	4,000	–	–	0.23%	61
2014 Q4	$637K	Hold	4,000	–	–	0.22%	61
2014 Q3	$562K	Hold	4,000	–	–	0.2%	62
2014 Q2	$473K	Hold	4,000	–	–	0.17%	64
2014 Q1	$493K	Buy	+4,000	New	+$485K	0.18%	61

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wilkins Investment Counsel's AMGN Position: Q1 2026 in Review

Wilkins Investment Counsel held its Amgen (AMGN) position steady in Q1 2026 at 751 shares worth $264K. The position accounts for 0.04% of the portfolio, ranked #110.

Wilkins Investment Counsel first reported a position in AMGN in Q1 2014 and has held it in 40 quarters since. The position peaked at $964K in Q4 2019. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Wilkins Investment Counsel held 751 shares of Amgen worth $264K as of Q1 2026.
Wilkins Investment Counsel left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.04% of Wilkins Investment Counsel's portfolio in Q1 2026, its #110 holding.
Wilkins Investment Counsel first reported a position in Amgen in Q1 2014 and has held it in 40 quarters since.
Wilkins Investment Counsel's Amgen position peaked at $964K in Q4 2019.
3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Wilkins Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.